Skip to main content
. 2015 Mar 27;118:56–67. doi: 10.1016/j.antiviral.2015.03.009

Fig. 5.

Fig. 5

Fig. 5

Antiviral effect of TF1, TF2, and TF3 against HSV-1 infected Vero (5a) and A549 (5b) cells as analyzed by flow cytometric system. The histograms depict GFP intensity from the GHSV-UL46 HSV-1 strain. (A) Vero cells only, (A′) A549 cells only (B, B′) untreated HSV-1, (C, C′) HSV-1 treated with DMSO, (D–F, D′–F′) HSV-1 treated with 25, 50, 75 μM of TF1, (G–I, G′–I′) HSV-1 treated with 25, 50, 75 μM of TF2, (J–L, J′–L′) HSV-1 treated with 25, 50, 75 μM of TF3.